177 related articles for article (PubMed ID: 9165227)
21. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
[TBL] [Abstract][Full Text] [Related]
22. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
23. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.
Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
Atherosclerosis; 2000 Sep; 152(1):229-37. PubMed ID: 10996359
[TBL] [Abstract][Full Text] [Related]
24. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
[TBL] [Abstract][Full Text] [Related]
25. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
Sánchez-Cabezudo M; Ródenas S; Cuesta C
Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
[TBL] [Abstract][Full Text] [Related]
26. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.
Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD
J Clin Endocrinol Metab; 1987 Sep; 65(3):512-8. PubMed ID: 3114304
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
Vergès B; Florentin E; Baillot-Rudoni S; Petit JM; Brindisi MC; Pais de Barros JP; Lagrost L; Gambert P; Duvillard L
J Lipid Res; 2009 Jun; 50(6):1209-15. PubMed ID: 19168444
[TBL] [Abstract][Full Text] [Related]
29. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
[TBL] [Abstract][Full Text] [Related]
30. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
Carreón-Torres E; Rendón-Sauer K; Monter-Garrido M; Toledo-Ibelles P; Gamboa R; Menjivar M; López-Marure R; Luc G; Fievet C; Cruz D; Vargas-Alarcón G; Pérez-Méndez O
Clin Chim Acta; 2009 Mar; 401(1-2):37-41. PubMed ID: 19036342
[TBL] [Abstract][Full Text] [Related]
32. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
Brinton EA; Eisenberg S; Breslow JL
J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.
Dean JD; Owens DR; Matthews SB
Diabetes Res; 1990 Sep; 15(1):21-5. PubMed ID: 2132196
[TBL] [Abstract][Full Text] [Related]
34. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
35. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.
Reznik Y; Pousse P; Herrou M; Morello R; Mahoudeau J; Drosdowsky MA; Fradin S
Metabolism; 1996 Jan; 45(1):63-71. PubMed ID: 8544779
[TBL] [Abstract][Full Text] [Related]
36. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
[TBL] [Abstract][Full Text] [Related]
37. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia.
Vega GL; Grundy SM
Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893
[TBL] [Abstract][Full Text] [Related]
38. Lecithin:cholesterol acyltransferase activity and high-density lipoprotein subfraction composition in type 1 diabetic patients with improving metabolic control.
Weight MJ; Coetzee HS; Smuts CM; Marais MP; Maritz JS; Hough FS; Benadé AJ; Taljaard JJ
Acta Diabetol; 1993; 30(3):159-65. PubMed ID: 8111077
[TBL] [Abstract][Full Text] [Related]
39. Serum lipid and lipoprotein metabolism after glucose ingestion in NIDDM and IGT patients. Apolipoprotein-containing particles.
Nagai T; Tomizawa T; Minamide S; Nakajima K; Mori M
Diabetes Care; 1996 Apr; 19(4):365-8. PubMed ID: 8729161
[TBL] [Abstract][Full Text] [Related]
40. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
